Unusual KRAS mutation in pancreatic cancer may explain less aggressive tumors

A study led by Aaron Hobbs, Ph.D., and Rachel Burge, Ph.D., at MUSC Hollings Cancer Center, reveals why a specific gene mutation behaves differently from other variants.

Continue Reading

News Source: medicalxpress.com